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1. Introduction 
A soluble enzyme complex participates in the 
biosynthesis of bacitracin which is an antibiotic 
dodecapeptide produced by a strain of Bacillus 
licheniformis and the peptide is synthesized from 
amino acids bdund to enzyme protein through 
thioester linkages [ 1,2] . These features of bacitracin 
synthetase resemble those in the biosynthesis of 
gramicidin S and tyrocidine [3]. Recently, it was 
reported that gramicidin S and tyrocidine synthetases 
contained one and two moles of 4’-phosphopante- 
theine pr mole of synthetase, respectively [4,5], and 
that phosphopantetheine arm participated in peptide 
chain elongation [6]. Bacitracin synthetase has beeri 
separated into two complementary fractions (Peaks 
I and II) by column chromatography on hydroxyapatite 
[2]. The present work demonstrates that Peak II frac- 
tion was further separated into two components and 
that each of the three components responsible for 
bacitracin biosynthesis contains approximately one 
equivalent of 4’-phosphopantetheine. 
2. Materials and methods 
2.1. Bacitracin synthetase 
The partially purified bacitracin synthetase was 
prepared from the crude extract of B. licheniformis 
ATCC 10716 as described previously [2] , and the 
hydroxyapatite fractions (Peaks I and II) were used 
throughout the work. 
2.2, Assay of A TP- 3 2 PPi exchange activity 
The incubating mixture and the procedure for assay 
of the exchange activity were as previously described 
North-Holland Publishing Company - Amsterdam 
except that bovine serum albumin (100 E.cg/ml) was 
added to the incubation mixture [2]. 
2.3. Estimation of the molecular weight 
The molecular weights of the three components of 
bacitracin synthetase were estimated by the methods 
of Martin and Ames [7]. The marker enzymes used 
were catalase (mol. wt 250 000) and urease (mol. wt 
480 000). 
2.4. Polyacrylamide disc gel electrophoresis 
Polya&ylamide gel electrophoresis was performed 
according to the methods of Davis [8]. 5% separation 
gels (0.5 X 8 cm, pH 8.9) and 2.5% stacking gels were 
prepared and electrophoresis was carried out in a cold 
room at 5°C with a constant current of 2 mA per tube 
for 2.5 hr. Three parallel experiments were performed. 
After electrophoresis, gel A was stained and scanned 
for protein absorbance using a densitometer. Gels B 
and C were sliced into uniform segments and used for 
assay of exchange activity and pantothenate content, 
respectively. 
2.5. Release of pantothenate from the enzyme protein 
Pantothenate was released from the enzyme protein 
according to the procedure of Pugh and Wakil [9]. 
The protein was hydrolyzed in 1 N NaOH at 100°C 
for 90-l 20 min. Then pH of the mixture was adjusted 
to about 10 with 1 N HCl. Glycine-NaCl-NaOH 
buffer (pH 9.6) and MgC12 were added to make final 
concentration 0.1 M and 1 mM, respectively. The 
mixture was incubated with alkaline phosphatase (10 
/..&1.5 ml) at 37’C for 2-3 hr. Controls without the 
addition of alkaline phosphatase were treated identi- 
cally. 
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2.6. Assay of pantothenate 
Pantothenate was determined by microbiological 
assay with Lactobacillus plantarum ATCC 80 14, using 
the medium based on USP description [lo]. 
2.7. Assay of /3-alanine and taurine 
Enzyme protein was treated with 0.1 N NaOH at 
70°C for 1 hr according to the method of Majerus et 
al. [ 111 for the liberation of 4’-phosphopantetheine. 
The solution was acidified with acetic acid and the 
resulting precipitate removed by centrifugation. The 
supernatant was concentrated under reduced pressure 
and submitted to oxidation with performic acid, as 
described by Hirs [ 121. Oxidized sample was hydro- 
lyzed in 6 N HCI in an evacuated sealed tube for 24 
hr at 110°C. The hydrolysate was analyzed with a 
Hitachi Model KLA3B amino acid analyzer. As a 
control experiment, CoA was treated in the same way 
as the enzyme protein. The recovery rate of (3-alanine 
and taurine from CoA was used for the calculation of 
the ratio of these substances in the enzyme protein. 
2.8. Measurement of protein concentration 
Protein concentration was determined by the 
method of Lowry et al. with bovine serum albumin as 
a standard [ 131. 
3. Results 
Bacitracin synthetase was resolved into two comple- 
mentary fractions by hydroxyapatite column chroma- 
tography as shown in fig.1. The mol. wt of Peak I was 
calculated to be about 200 000 from the profde of 
sucrose density gradient centrifugation (fig.2). Figs. 3 
and 4 show that Peak II was further separated into 
two main components. The light fraction which acti- 
vated L-lysine and L-ornithine has the mol. wt of 
about 210 000 and the heavy one, which activated 
Lisoleucine, L- and D-phenylalanine, L-histidine, L- 
aspartate and L-asparagine, has the mol. wt of about 
380 000. The former fraction is now termed as 
Component II and the latter Component III, and then 
Peak I is termed as Component I. 
In preliminary experiments, it was found that 
Peak II contained about two moles of pantothenate 
per mole of fraction. Pantothenate was then assayed 
for the fractions obtained by disc electrophoresis of 
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Fig.1. Resolution of bacitracin synthetase into two comple- 
mentary fractions by hydroxyapatite column chromatography. 
The column (1.2 X 13 cm) was eluted with a linear gradient 
consisting of 75 ml each of 0.15 M and 0.30 M potassium 
phosphate buffer (pH 6.8). Protein (X-X-X ); ATP-3z PPi 
exchange activities dependent on L-cysteine ( -) and D- 
phenylalanine (-). 
Bat tom Fraction no. (0.14ml each) Top 
Fig.2. Sucrose density gradient centrifugation of Peak I. A 4 
to 16% linear sucrose gradient (4.4 ml) containing 50 mM 
Tris-HCl (pH 7.4), 1 mM MgCl, and 5 mM dithiothreitol 
was used. Peak I (200 pg) and marker enzymes were layered 
and centrifuged at 100 000 g for 11 hr. In parallel experi- 
ment the sample solution without markers was centrifuged. 
Two fractions were combined and used for pantothenate deter- 
mination. ATP-” PPi exchange activity dependent on L-cys- 
teine (-); Pantothenate content (a). 
peak II where Components II and III were distinctly 
separated. Fig.4 shows that both Components contain 
pantothenate. In the case of Component I, pantothe- 
nate was assayed for the fractions obtained by sucrose 
density gradient centrifugation owing to a fairly low 
yield of pantothenate from the fractions obtained by 
disceiectrophoresis. As shown in fig.2, it is clear that 
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Fig. 3. Sucrose density gradient centrifugation of Peak IL A 4 to 
16% linear sucrose gradient (4.4 ml) containing 0.3 M potassium 
phosphate buffer (pH 7.2) and 5 mM dithiothreitol was used. 
Peak II (90 pg) and marker enzymes were layered and centri- 
fuged at 130 000 g for 7 hr. ATP-s2 PPi exchange activities 
dependent on a mixture of L-lysine and L-ornithine (o-+o), 
and L-histidine (e-e-e). 
Component I also contains pantothenate. As summa- 
rized in table I, each Components contains about one 
mole of pantothenate per mole of Component. 
Since pantothenate was not released from the 
enzyme protein without both alkali and alkaline phos- 
phatase treatments and phosphopantothenate released 
by alkali treatment was very stable under alkaline 
conditions, it is suggested that pantothenate is present 
as 4’.phosphopantothenate [141. By the amino acid 
analysis of performic acid-treated enzyme protein, it 
was shown that the ratio of taurine to /Uanine was 
1.1: 1 and 0.9: 1 for Peaks I and II, respectively. This 
suggests that phosphopantothenate is present as phos- 
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Fig.4. Polyacrylamide gel electrophoresis of Peak II. 170 pg 
fo Peak II was applied to each of four gels. For good separa- 
tion of each of the protein components, electrophoresis was 
continued further for 2 hr after bromphenol blue marker 
emerged from gel at about 2.5 hr. Protein absorbance (-_); 
Pantothenate content (o--c-o); ATP-n PPi exchange activities 
dependent on a mixture of L-histidine, L-aspartate and Gaspar- 
agine (o-se), a mixture of L-lysine and L-ornithine (c--u), 
L-isoleucine (X-X-X), and D-phenylalanine (A-La). 
phopantetheine. Following results may eliminate the 
possibility that phosphopantetheine was derived from 
CoA adventitiously bound to the enzyme protein; (1) 
previous thorough dialysis of enzyme solution against 
8 M urea-l mM dithiothreitol had no effect on the 
yield of pantothenate. (2) When CoA was subjected 
Table 1 
Phosphopantetheine content of three components of bacitracin synthetase 
Enzyme fraction Amino acid Mol. wt Purity Phosphopantetheine 
activated (%) (mol/mol fraction) 
Component I L-Ile, LCys 200 000 70 1.3 
L-Leu, LGlu 
Component II L-Lys, L-Cm 2:o 000 40 0.6 
Component III L-Ile, L-and 380 000 40 1.3 
D-Phe, L-His 
L-Asp, L-Asn 
*Components II and III were derived from Peak II, therefore the purity of Peak II was 
about 80% as to bacitracin synthetase. 
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to alkali treatment in 1 N NaOH at 105”C, phospho- 
pantothenate liberated from CoA increased linearly 
with time and about 30% of CoA was hydrolyzed in 
4 hr. With enzyme protein, however, almost all phos- 
phopantothenate was liberated within 1 hr under the 
same conditions. 
4. Discussion 
The present results revealed that bacitracin syn- 
thetase was composed of three components being 
dissociated under a mild condition, Frbyshov also 
reported the same result [ 1.51. A minor protein band 
having only the L-phenylalanine- and L-isoleucine-acti- 
vating activity was detected in disc electrophoresis as 
shown in fig.4, suggesting a possible separation of 
bacitracin synthetase complex into further smaller 
components. 
Each of the three Components proved to possess 
about one equivalent of 4’-phosphopantetheine. How- 
ever, the possibility that bacitracin synthetase contained 
originally one phosphopantetheine-containing protein 
and this protein associated at random with the three 
Components could be ruled out by the following 
results. When a Sephadex G-200 fraction, on the 
purification step previous to hydroxyapatite column 
chromatography [2] and this containing all of the 
three Components, was assayed for pantothenate, 
about three equivalents of pantothenate were detected, 
assuming a mol. wt of 800 000 for whole bacitracin 
synthetase. 
From the results presented here as well as those in 
gramicidin S and tyrocidine systems [4,5], it may be 
generally said that in antibiotic polypeptide synthetase 
each of the enzyme complex, which has more than 
two active sites and which seems to dissociate from 
each other under physiological conditions, contains 
one equivalent of phosphopantetheine. 
Present results show that the transpeptidation and 
transthiolation reactions mediated by enzyme-bound 
phosphopantetheine arm as demonstrated in gramici- 
din S and tyrocidine biosynthesis [6,16] probably 
operate also in bacitracin biosynthesis. 
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